Have a personal or library account? Click to login
Effect of plant polyphenols on seizures – animal studies Cover

Effect of plant polyphenols on seizures – animal studies

Open Access
|Dec 2013

References

  1. Abbasi E., Nassiri-Asl M., Shafeei M., Sheikhi M.: Neuroprotective effects of vitexin, a flavonoid, on pentylenetetrazole-in-duced seizure in rats. Chem. Biol. Drug Des., 2012, 80: 274–278. Abd El Mohsen M.M., Kuhnle G., Rechner A.R., Schroeter H., Rose S., Jenner P., Rice-Evans C.A.: Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free. Radic. Biol. Med., 2002, 33: 1693–1702.
  2. Andres-Lacueva C., Shukitt-Hale B., Galli R.L., Jauregui O., Lamuela-Raventos R.M., Joseph J.A.: Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory. Nutr. Neurosci., 2005, 8: 111–120.10.1080/10284150500078117
  3. Beking K. and Vieira A.: Flavonoid intake and disability-adjusted life years due to Alzheimer’s and related dementias: a population-based study involving twenty-three developed countries. Public Health Nutr., 2010, 13: 1403–1409.10.1017/S1368980009992990
  4. Commenges D., Scotet V., Renaud S., Jacqmin-Gadda H., Barberger-Gateau P., Dartigues J.F.: Intake of flavonoids and risk of dementia. Eur. J. Epidemiol., 2000, 16: 357–363.10.1023/A:1007614613771
  5. Crozier A., Jaganath I.B., Clifford M.N.: Dietary phenolics: chemistry, bioavailability and effects on health. Nat. Prod. Rep., 2009, 26: 1001–1043.10.1039/b802662a
  6. de Carvalho R.S., Duarte F.S., de Lima T.C.: Involvement of GABAergic non-benzodiazepine sites in the anxiolytic-like and sedative effects of the flavonoid baicalein in mice. Behav. Brain Res., 2011, 221: 75–82.10.1016/j.bbr.2011.02.038
  7. Dimpfel W.: Different anticonvulsive effects of hesperidin and its aglycone hesperetin on electrical activity in the rat hippocampus in-vitro. J. Pharm. Pharmacol., 2006, 58: 375–379. Du X.M., Sun N.Y., Takizawa N., Guo Y.T., Shoyama Y.: Sedative and anticonvulsant activities of goodyerin, a flavonol glycoside from Goodyera schlechtendaliana. Phytother. Res., 2002, 16: 261–263.
  8. Faria A., Pestana D., Teixeira D., Couraud P.O., Romero I., Weksler B. et al.: Insights into the putative catechin and epicatechin transport across blood-brain barrier. Food Funct., 2011, 2: 39–44.10.1039/C0FO00100G
  9. Fernández S.P., Wasowski C., Loscalzo L.M., Granger R.E., Johnston G.A., Paladini A.C., Marder M.: Central nervous system depressant action of flavonoid glycosides. Eur. J. Pharmacol., 2006, 539: 168–176.10.1016/j.ejphar.2006.04.004
  10. Friedman L.K., Goldstein B., Rafiuddin A., Roblejo P., Friedman S.: Lack of resveratrol neuroprotection in developing rats treated with kainic acid. Neuroscience, 2013, 230: 39–49.10.1016/j.neuroscience.2012.10.063
  11. Garg S.K., Kumar N., Bhargava V.K., Prabhakar S.K.: Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy. Clin. Pharmacol. Ther., 1998, 64: 286–288.10.1016/S0009-9236(98)90177-1
  12. Golechha M., Chaudhry U., Bhatia J., Saluja D., Arya D.S.: Naringin protects against kainic acid-induced status epilep-ticus in rats: evidence for an antioxidant, anti-inflammatory and neuroprotective intervention. Biol. Pharm. Bull., 2011, 34: 360–365.10.1248/bpb.34.36021372385
  13. Griebel G., Perrault G., Tan S., Schoemaker H., Sanger D.J.: Pharmacological studies on synthetic flavonoids: comparison with diazepam. Neuropharmacology, 1999, 38: 965–977.10.1016/S0028-3908(99)00026-X
  14. Gupta Y.K., Briyal S., Chaudhary G.: Protective effect of trans-resveratrol against kainic acid-induced seizures and oxidative stress in rats. Pharmacol. Biochem. Behav., 2002b, 71: 245–249.10.1016/S0091-3057(01)00663-3
  15. Gupta Y.K., Chaudhary G., Sinha K., Srivastava A.K.: Protective effect of resveratrol against intracortical FeCl2-induced model of posttraumatic seizures in rats. Methods Find. Exp. Clin. Pharmacol., 2001, 23: 241–244.10.1358/mf.2001.23.5.66212011712643
  16. Gupta Y.K., Chaudhary G., Srivastava A.K.: Protective effect of resveratrol against pentylenetetrazole-induced seizures and its modulation by an adenosinergic system. Pharmacology, 2002a, 65: 170–174.10.1159/00005804412037381
  17. Hamada H., Hiramatsu M., Edamatsu R., Mori A.: Free radical scavenging action of baicalein. Arch. Biochem. Biophys., 1993, 306: 261–266.10.1006/abbi.1993.15098215413
  18. Han J.Y., Ahn S.Y., Kim C.S., Yoo S.K., Kim S.K., Kim H.C. et al.: Protection of apigenin against kainate-induced excitotoxicity by anti-oxidative effects. Biol. Pharm. Bull., 2012, 35: 1440–1446.10.1248/bpb.b11068622975493
  19. Hu K., Li S.Y., Xiao B., Bi F.F., Lu X.Q., Wu X.M.: Protective effects of quercetin against status epilepticus induced hippocampal neuronal injury in rats: involvement of X-linked inhibitor of apoptosis protein. Acta Neurol. Belg., 2011, 111: 205–212.
  20. Joshi D., Naidu P.S., Singh A., Kulkarni S.K.: Protective effect of quercetin on alcohol abstinence-induced anxiety and convulsions. J. Med. Food, 2005, 8: 392–396.10.1089/jmf.2005.8.39216176153
  21. Kabuto H., Yokoi I., Mori A.: Monoamine metabolites, iron induced seizures, and the anticonvulsant effect of tannins. Neurochem Res., 1992, 17: 585–590.10.1007/BF00968787
  22. Kavvadias D., Sand P., Youdim K.A., Qaiser M.Z., Rice-Evans C., Baur R. et al.: The flavone hispidulin, a benzodiazepine receptor ligand with positive allosteric properties, traverses the blood-brain barrier and exhibits anticonvulsive effects. Br. J. Pharmacol., 2004, 142: 811–820.10.1038/sj.bjp.0705828
  23. Kim H.J., Kim I.K., Song W., Lee J., Park S.: The synergic effect of regular exercise and resveratrol on kainate-induced oxidative stress and seizure activity in mice. Neurochem Res., 2013, 38: 117–122.10.1007/s11064-012-0897-8
  24. Kumar A., Lalitha S., Mishra J.: Possible nitric oxide mechanism in the protective effect of hesperidin against pentylene-tetrazole (PTZ)-induced kindling and associated cognitive dysfunction in mice. Epilepsy Behav., 2013, 29: 103–111.10.1016/j.yebeh.2013.06.007
  25. Lin T.Y., Lu C.W., Wang C.C., Lu J.F., Wang S.J.: Hispidulin inhibits the release of glutamate in rat cerebrocortical nerve terminals. Toxicol. Appl. Pharmacol., 2012, 263: 233–243.10.1016/j.taap.2012.06.015
  26. Liu Y.F., Gao F., Li X.W., Jia R.H., Meng X.D., Zhao R., Jing Y.Y. et al.: The anticonvulsant and neuroprotective effects of baicalin on pilocarpine-induced epileptic model in rats. Neurochem. Res., 2012, 37: 1670–1680.10.1007/s11064-012-0771-8
  27. Majkowski J.: Epileptogenesis – the role of oxygen stress. Epileptologia, 2007, 15: 225–240.
  28. Medina J.H., Paladini A.C., Wolfman C., Levi de Stein M., Calvo D., Diaz L.E., Peña C.: Chrysin (5,7-di-OH-flavone), a naturally-occurring ligand for benzodiazepine receptors, with anticonvulsant properties. Biochem. Pharmacol., 1990, 40: 2227–2231.10.1016/0006-2952(90)90716-X
  29. Metzler M., Pfeiffer E., Schulz S.I., Dempe J.S.: Curcumin uptake and metabolism. Biofactors, 2013, 39: 14–20.10.1002/biof.1042
  30. Nassiri-Asl M., Moghbelinejad S., Abbasi E., Yonesi F., Haghighi MR., Lotfizadeh M., Bazahang P.: Effects of quercetin on oxidative stress and memory retrieval in kindled rats. Epilepsy Behav., 2013, 28: 151–155.10.1016/j.yebeh.2013.04.019
  31. Nassiri-Asl M., Mortazavi S.R., Samiee-Rad F., Zangivand A.A., Safdari F., Saroukhani S., Abbasi E.: The effects of rutin on the development of pentylenetetrazole kindling and memory retrieval in rats. Epilepsy Behav., 2010, 18: 50–53.10.1016/j.yebeh.2010.03.00520452834
  32. Nassiri-Asl M., Shariati-Rad S., Zamansoltani F.: Anticonvulsive effects of intracerebroventricular administration of rutin in rats. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2008, 32: 989–993.10.1016/j.pnpbp.2008.01.01118262708
  33. Nitsinskaia L.E., Ekimova I.V., Guzhova I.V., Feĭzulaev B.A., Pastukhov Iu F.: Effect of quercetin on the severity of chemically induced seizures and the content of heat shock protein 70 in the rat brain structures. Ross. Fiziol. Zh. Im. I.M. Sechenova., 2010, 96: 283–292.
  34. Nones J.E., Spohr T.C., Gomes F.C.: Hesperidin, a flavone glycoside, as mediator of neuronal survival. Neurochem. Res., 2011, 36: 1776–1784.10.1007/s11064-011-0493-321553255
  35. Nugroho A., Lim SC., Choi J., Park H.J.: Identification and quantification of the sedative and anticonvulsant flavone glycoside from Chrysanthemum boreale. Arch Pharm Res., 2013, 36: 51–60.10.1007/s12272-013-0015-823325489
  36. Shetty A.K.: Promise of resveratrol for easing status epilepticus and epilepsy. Pharmacol. Ther., 2011, 131: 269–286.10.1016/j.pharmthera.2011.04.008
  37. Svenningsen A.B., Madsen K.D., Liljefors T., Stafford G.I., van Staden J., Jäger A.K.: Biflavones from Rhus species with affinity for the GABA(A)/benzodiazepine receptor. J. Ethnop-harmacol., 2006, 103: 276–280.10.1016/j.jep.2005.08.012
  38. Tsaryuk V.V., Potapovich A.I., Kostyuk V.A.: Protective effect of copper-rutin complex in animals with experimental epilepsy. Bull. Exp. Biol. Med., 2002, 133: 334–335.10.1023/A:1016277400515
  39. Vauzour D., Vafeiadou K., Rice-Evans C., Williams R.J., Spencer J.P.: Activation of pro-survival Akt and ERK1/2 signalling pathways underlie the anti-apoptotic effects of flavanones in cortical neurons. J. Neurochem., 2007, 103: 1355– 1367.10.1111/j.1471-4159.2007.04841.x
  40. Wang F., Xu Z., Ren L., Tsang S.Y., Xue H.: GABAA receptor subtype selectivity underlying selective anxiolytic effect of baicalin. Neuropharmacology, 2008, 55: 1231–1237.10.1016/j.neuropharm.2008.07.040
  41. Wang S.J., Bo Q.Y., Zhao X.H., Yang X., Chi Z.F., Liu X.W.: Resveratrol pre-treatment reduces early inflammatory responses induced by status epilepticus via mTOR signaling. Brain Res., 2013, 1492: 122–129.10.1016/j.brainres.2012.11.027
  42. Witkin J.M., Terry P., Menkel M., Hickey P., Pontecorvo M., Ferkany J., Katz J.L.: Effects of the selective sigma receptor ligand, 6-[6-(4-hydroxypiperidinyl)hexyloxy]-3-methylflavone (NPC 16377), on behavioral and toxic effects of cocaine. J. Pharmacol. Exp. Ther., 1993, 266: 473–482.
  43. Wolfman C., Viola H., Marder M., Ardenghi P., Wasowski C., Schröder N. et al.: Pharmacological characterization of 6-bromo-3’-nitroflavone, a synthetic flavonoid with high affinity for the benzodiazepine receptors. Pharmacol. Biochem. Behav., 1998, 61: 239–246.10.1016/S0091-3057(98)00088-4
  44. Wu Z., Xu Q., Zhang L., Kong D., Ma R., Wang L.: Protective effect of resveratrol against kainate-induced temporal lobe epilepsy in rats. Neurochem. Res., 2009, 34: 1393–1400.10.1007/s11064-009-9920-0
  45. Xie T., Wang W.P., Mao Z.F., Qu Z.Z., Luan S.Q., Jia L.J., Kan M.C.: Effects of epigallocatechin-3-gallate on pentylene-tetrazole-induced kindling, cognitive impairment and oxidative stress in rats. Neurosci. Lett., 2012, 516: 237–241.10.1016/j.neulet.2012.04.001
  46. Yoon S.Y., dela Peña I.C., Shin C.Y., Son K.H., Lee Y.S., Ryu J.H. et al.: Convulsion-related activities of Scutellaria flavones are related to the 5,7-dihydroxyl structures. Eur. J. Pharmacol., 2011, 659: 155–160.10.1016/j.ejphar.2011.03.01221440538
  47. Yokoi I., Kabuto H., Akiyama K., Mori A., Ozaki M.: Tannins inhibit the occurrence of epileptic focus induced by FeCl3 injection in rats. Jpn. J. Psychiatry Neurol., 1989, 43: 552–553.10.1111/j.1440-1819.1989.tb02979.x2516577
DOI: https://doi.org/10.21307/joepi-2015-0007 | Journal eISSN: 2299-9728 | Journal ISSN: 2300-0147
Language: English
Page range: 79 - 87
Submitted on: Oct 11, 2013
|
Accepted on: Nov 28, 2013
|
Published on: Dec 4, 2013
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2013 Władysław Lasoń, Monika Leśkiewicz, published by The Foundation of Epileptology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.